198 related articles for article (PubMed ID: 22244378)
21. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
Nguyen KH; Gordon LG
Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
[TBL] [Abstract][Full Text] [Related]
22. Brain SPECT guided repetitive transcranial magnetic stimulation (rTMS) in treatment resistant major depressive disorder.
Jha S; Chadda RK; Kumar N; Bal CS
Asian J Psychiatr; 2016 Jun; 21():1-6. PubMed ID: 27208445
[TBL] [Abstract][Full Text] [Related]
23. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
[TBL] [Abstract][Full Text] [Related]
24. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS).
Langguth B; Wiegand R; Kharraz A; Landgrebe M; Marienhagen J; Frick U; Hajak G; Eichhammer P
Neuro Endocrinol Lett; 2007 Oct; 28(5):633-8. PubMed ID: 17984932
[TBL] [Abstract][Full Text] [Related]
25. Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmacoresistant depression using either high-frequency left or low-frequency right prefrontal rTMS.
Richieri R; Boyer L; Padovani R; Adida M; Colavolpe C; Mundler O; Lançon C; Guedj E
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):364-70. PubMed ID: 22850205
[TBL] [Abstract][Full Text] [Related]
26. Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy.
Levitt JG; Kalender G; O’Neill J; Diaz JP; Cook IA; Ginder N; Krantz D; Minzenberg MJ; Vince-Cruz N; Nguyen LD; Alger JR; Leuchter AF
J Psychiatry Neurosci; 2019 Nov; 44(6):386-394. PubMed ID: 31199104
[TBL] [Abstract][Full Text] [Related]
27. Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis.
Lan MJ; Chhetry BT; Liston C; Mann JJ; Dubin M
Brain Stimul; 2016; 9(4):577-83. PubMed ID: 27017072
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of dorso-lateral prefrontal connectivity for rTMS response in treatment-resistant depression: A brain perfusion SPECT study.
Richieri R; Verger A; Boyer L; Boucekine M; David A; Lançon C; Cermolacce M; Guedj E
Brain Stimul; 2018; 11(5):1093-1097. PubMed ID: 29802071
[TBL] [Abstract][Full Text] [Related]
29. Differentiating responders and non-responders to rTMS treatment for depression after one week using resting EEG connectivity measures.
Bailey NW; Hoy KE; Rogasch NC; Thomson RH; McQueen S; Elliot D; Sullivan CM; Fulcher BD; Daskalakis ZJ; Fitzgerald PB
J Affect Disord; 2019 Jan; 242():68-79. PubMed ID: 30172227
[TBL] [Abstract][Full Text] [Related]
30. Examining the neural mechanisms of rTMS: a naturalistic pilot study of acute and serial effects in pharmacoresistant depression.
Cosmo C; Zandvakili A; Petrosino NJ; Toutain TGLO; Miranda JGV; Philip NS
Front Neural Circuits; 2023; 17():1161826. PubMed ID: 37206978
[TBL] [Abstract][Full Text] [Related]
31. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.
Wall CA; Croarkin PE; Maroney-Smith MJ; Haugen LM; Baruth JM; Frye MA; Sampson SM; Port JD
J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):582-9. PubMed ID: 26849202
[TBL] [Abstract][Full Text] [Related]
32. Transcranial Magnetic Stimulation Modulates Resting EEG Functional Connectivity Between the Left Dorsolateral Prefrontal Cortex and Limbic Regions in Medicated Patients With Treatment-Resistant Depression.
Kito S; Hasegawa T; Takamiya A; Noda T; Nakagome K; Higuchi T; Koga Y
J Neuropsychiatry Clin Neurosci; 2017; 29(2):155-159. PubMed ID: 27852164
[TBL] [Abstract][Full Text] [Related]
33. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation.
Holtzheimer PE; Russo J; Claypoole KH; Roy-Byrne P; Avery DH
Depress Anxiety; 2004; 19(1):24-30. PubMed ID: 14978782
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression.
Fitzgerald PB; Huntsman S; Gunewardene R; Kulkarni J; Daskalakis ZJ
Int J Neuropsychopharmacol; 2006 Dec; 9(6):655-66. PubMed ID: 16959055
[TBL] [Abstract][Full Text] [Related]
35. Non-linear EEG analyses predict non-response to rTMS treatment in major depressive disorder.
Arns M; Cerquera A; Gutiérrez RM; Hasselman F; Freund JA
Clin Neurophysiol; 2014 Jul; 125(7):1392-9. PubMed ID: 24360132
[TBL] [Abstract][Full Text] [Related]
36. Actigraphy in Patients With Major Depressive Disorder Undergoing Repetitive Transcranial Magnetic Stimulation: An Open Label Pilot Study.
Nishida M; Kikuchi S; Nisijima K; Suda S
J ECT; 2017 Mar; 33(1):36-42. PubMed ID: 27611301
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression.
Fitzgerald PB; Hoy K; Gunewardene R; Slack C; Ibrahim S; Bailey M; Daskalakis ZJ
Psychol Med; 2011 Jun; 41(6):1187-96. PubMed ID: 20925972
[TBL] [Abstract][Full Text] [Related]
38. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
[TBL] [Abstract][Full Text] [Related]
39. Predicting treatment response using EEG in major depressive disorder: A machine-learning meta-analysis.
Watts D; Pulice RF; Reilly J; Brunoni AR; Kapczinski F; Passos IC
Transl Psychiatry; 2022 Aug; 12(1):332. PubMed ID: 35961967
[TBL] [Abstract][Full Text] [Related]
40. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
